✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Ghrelin Receptor Research Peptide
Ipamorelin is a selective growth hormone secretagogue studied in laboratory settings for its ability to stimulate GH release through ghrelin receptor pathways. Research often explores its effects on recovery-related signaling, protein metabolism, and regulation of growth hormone dynamics in controlled experimental models.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Ipamorelin is a synthetic peptide developed for controlled laboratory research involving ghrelin receptor signaling systems. It is structurally designed to interact with growth hormone secretagogue receptor (GHS-R1a) pathways within experimental environments.
In scientific literature, ipamorelin is studied in models examining receptor-mediated signaling cascades, endocrine pathway interaction, and downstream cellular response systems under in vitro and preclinical research conditions.
Third-party tested for purity, ID, quantity.
Ipamorelin is a selective synthetic growth hormone secretagogue evaluated in research focused on ghrelin receptor activity and endocrine signaling pathways. Experimental studies examine receptor interaction models, hypothalamic-pituitary signaling systems, and regulated peptide response mechanisms.
Preclinical research publications have explored its receptor-binding characteristics and downstream signaling behavior within controlled laboratory environments.
Ipamorelin was developed during research efforts investigating selective growth hormone secretagogues with targeted receptor interaction. Studies explored its specificity toward ghrelin receptor pathways and its role within endocrine signaling research frameworks.
Subsequent experimental work documented its receptor interaction profile and signaling characteristics in laboratory models.
Laboratory investigations into ipamorelin have focused on ghrelin receptor activation models and endocrine-related signaling pathways. Research frameworks evaluate receptor-mediated interaction, peptide specificity, and downstream regulatory mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of lyophilized ipamorelin. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the lyophilized peptide. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Related
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
